Mizuho Trust & Banking’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-457,245
Closed -$57.3M 226
2016
Q3
$57.3M Buy
457,245
+7,117
+2% +$919K 0.17% 138
2016
Q2
$59.1M Buy
450,128
+36,850
+9% +$5.04M 0.18% 129
2016
Q1
$57.4M Buy
413,278
+16,486
+4% +$2.2M 0.18% 123
2015
Q4
$55.9M Buy
396,792
+2,093
+0.5% +$288K 0.18% 129
2015
Q3
$55.3M Buy
394,699
+7,771
+2% +$1.17M 0.19% 121
2015
Q2
$63.5M Buy
386,928
+6,895
+2% +$1.1M 0.21% 112
2015
Q1
$58.7M Buy
380,033
+10,352
+3% +$1.47M 0.2% 112
2014
Q4
$46.5M Buy
369,681
+11,903
+3% +$1.47M 0.16% 136
2014
Q3
$43M Sell
357,778
-26,184
-7% -$3M 0.16% 138
2014
Q2
$41.3M Sell
383,962
-22,019
-5% -$2.27M 0.15% 152
2014
Q1
$40.4M Sell
405,981
-17,430
-4% -$1.58M 0.15% 151
2013
Q4
$37.9M Buy
423,411
+2,790
+0.7% +$248K 0.14% 163
2013
Q3
$34.4M Hold
420,621
0.14% 154
2013
Q2
$34.4M Buy
+420,621
New +$31.5M 0.15% 153

Other funds holding ELV

Mizuho Trust & Banking's ELV Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Elevance Health (ELV) in Q4 2016, closing a stake of 457,245 shares — an estimated $57.3M sold.

Mizuho Trust & Banking first reported a position in ELV in Q2 2013 and held it in 14 quarters. The position peaked at $63.5M in Q2 2015. 784 funds tracked by Wall St. Rank hold ELV as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Elevance Health position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 457,245 Elevance Health shares in Q4 2016, an estimated $57.3M.
  • Mizuho Trust & Banking first reported a position in Elevance Health in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's Elevance Health position peaked at $63.5M in Q2 2015.
  • 784 funds tracked by Wall St. Rank held Elevance Health as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.